The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now, the drug is approved for use in two rare forms of epilepsy – Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age
Imagine stepping onto a scale not to measure your weight, but the chance of your heart failure. That's the potential scenario envisioned by researchers who may have discovered a new risk factor for heart failure: leg bioimpedance. More frequently used to calculate body fat, bioimpedance uses low electrical currents to measure resistance within the tissue. The study was published in the Journal of the American Heart Association.
Researchers found that people who had lower leg bioimpedance were at higher risk for heart failure. The discovery could potentially lead to earlier diagnosis and preemptive treatment of the condition.
Schoolgirls can achieve lower blood pressure, stronger muscles, better balance and improved jumping performance if their school puts football training on the timetable—including girls who have never played football before.
Scientists are unveiling how our immune system works and malfunctions thanks to an innovative technology that tracks immune cells. The technology has already been used to look at immune cells involved in a mouse model of multiple sclerosis and could provide valuable insights into autoimmune diseases.
A novel positron emission tomography (PET) tracer has been developed that can accurately image cardiovascular infections, which are extremely dangerous and have a high fatality rate. The research was presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
According to a new study, researchers examine that people in middle age, you might be guarding against not only depression as a senior, but also dying from heart disease if you do develop depression. Among nearly 18,000 Medicare patients, the most fit was 16% less likely to develop depression, the researchers found. The fittest were also 56% less likely to die from heart disease if they developed depression, and 61% less likely to die from heart disease if they remained free from depression. The study was published online in the journal JAMA Psychiatry.
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Advanced MRI technology reveals previously undetectable brain damage induced by hypertension, a major risk factor for dementia. The study was led by Lorenzo Carnevale, from the Department of Angiocardioneurology and Translational Medicine at the IRCCS Neuromed, Italy.
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for ulipristal acetate (Gedeon Richter) for preoperative treatment of uterine fibroids
Researchers at the University of Leicester and Meningococcal Reference Unit have developed a new approach to assess the effectiveness of the Men B vaccine, Bexsero®, against different strains that cause meningococcal meningitis and septicaemia.
Research by UC Santa Cruz doctoral student Julia Soares has found compelling evidence that the act of taking a photograph impairs people's memories of the event. People think that taking a photo will help them remember something better, but it's actually quite the contrary. In a set of experiments, she invited people to her lab for a virtual museum tour where they looked at paintings on computer screens, knowing they would be tested on what they saw.
Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates for the first time the benefit of providing earlier lutetium-177 (177Lu) prostate-specific membrane antigen (PSMA) radioligand therapy.